pneumonia
ACIP Recommends Capvaxive for Certain Adults Ages 19 and Older
The ACIP unanimously voted to recommend Capvaxive to vaccinate certain adults ages 19 and older to protect against ...
JULY 2, 2024

FDA Approves Capvaxive Pneumonia Vaccine
The FDA approved Capvaxive for adults to prevent against invasive pneumococcal disease and pneumonia caused ...
JUNE 24, 2024

ACIP Recommends Pneumococcal Vaccines for Certain Immunocompromised Adults
The risk factors in younger people included alcoholism, chronic heart, liver or lung disease, cigarette smoking, ...
NOVEMBER 3, 2021

Certain Psychiatric Drugs May Raise Pneumonia Risk
The use of benzodiazepines and benzodiazepine-related drugs could increase the risk for community-acquired ...
JANUARY 10, 2019
